The Department of Health's Therapeutic Goods Administration (TGA) has initiated proceedings in the Federal Court of Australia in response to the alleged unlawful advertising of Miracle Mineral Supplement (also referred to as Miracle Mineral Solution) (MMS), dimethyl sulfoxide (DMSO) and other medicines by Southern Cross Directories Pty Ltd trading as MMS Australia.
The TGA recently issued MMS Australia with twelve infringement notices totalling $151,200 for alleged unlawful advertising. The TGA also informed MMS Australia that it must immediately remove all advertisements in breach of the Therapeutic Goods Act 1989 (the Act), and warned that court action may be initiated if the advertisements were not removed within two days.
MMS Australia did not remove the allegedly unlawful advertising. The TGA has therefore initiated court proceedings to obtain an injunction restraining MMS Australia and its director, Charles Barton, from advertising or supplying the relevant goods. The TGA will also seek orders that MMS Australia and Mr Barton pay penalties for alleged contraventions of the Act.
The TGA has taken this action to address the public health risks that may arise from the ongoing advertising and supply of products that are not approved as therapeutic goods in Australia.
The TGA is particularly concerned about the harmful effects that can be caused by the ingestion of MMS, and has published a safety alert
